Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Chloroquine - Checkpoint (Istex)

Index « Teeft.i » - entrée « Biochem pharmacol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Biochem pharmac < Biochem pharmacol < Biochem pharmacol lagneaux  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 24.
[0-20] [0 - 20][0 - 24][20-23][20-40]
Ident.Authors (with country if any)Title
000629 (2010) Joo H. Lee [Corée du Sud] ; Si H. Yang [Corée du Sud] ; Jung M. Oh [Corée du Sud] ; Myung G. Lee [Corée du Sud]Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus
000992 (2007) Suryanaryana Vangapandu [Inde, États-Unis] ; Meenakshi Jain [Inde] ; Kirandeep Kaur [Inde] ; Premanand Patil [Inde] ; Sanjay R. Patel [Inde] ; Rahul Jain [Inde]Recent advances in antimalarial drug development
000A59 (2007) Andrew J. HuttCHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
000C88 (2005) M. Sterba [République tchèque] ; T. Simunek [République tchèque] ; Y. Mazurová ; M. Adamcová ; O. Popelová ; J. Kaplanová [République tchèque] ; P. Ponka [Canada] ; V. Gersl [République tchèque]Safety and tolerability of repeated administration of pyridoxal 2-chlorobenzoyl hydrazone in rabbits
001214 (2001) J. Lieb [États-Unis]Eicosanoids: the molecules of evolution
001240 (2001) J. Lieb [États-Unis]Antidepressants, eicosanoids and the prevention and treatment of cancer. A Review
001307 (2000) Marko Vezmar [Canada] ; Elias Georges [Canada]Reversal of MRP-mediated doxorubicin resistance with quinoline-based drugs
001326 (2000) R. Ritch [États-Unis]Potential role for Ginkgo biloba extract in the treatment of glaucoma
001449 (1999) P. B. Jensen [Danemark] ; M. Sehested [Danemark] ; S. W. Langer [Danemark] ; H. H. Hansen [Danemark]Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory
001491 (1999) Rachida Legssyer [Belgique] ; Roberta J. Ward [Belgique] ; Robert R. Crichton [Belgique] ; Johan R. Boelaert [Belgique]Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages
001620 (1998) Géraldine Pron [France] ; Nawel Mahrour [France] ; Stéphane Orlowski [France] ; Omar Tounekti [France] ; Bruno Poddevin [France] ; Jean Belehradek [France] ; Lluis M. Mir [France]Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism
001631 (1998) Marko Vezmar [Canada] ; Elias Georges [Canada]Direct binding of chloroquine to the multidrug resistance protein (MRP)
001649 (1997) Xavier Bosch [Espagne] ; Alfonso Lopez-Soto [Espagne] ; Antonio Morello [Espagne] ; Angel Olmo [Espagne] ; Alvaro Urbano-Marqlez [Espagne]Vitamin D Metabolite-Mediated Hypercalcemia in Wegener's Granulomatosis
001666 (1997) Stanley Mukanganyama [Zimbabwe] ; Collen M. Masimirembwa [Zimbabwe] ; Yogeshkumar S. Naik [Zimbabwe] ; Julia A. Hasler [Zimbabwe]Phenotyping of the glutathione S-transferase M1 polymorphism in Zimbabweans and the effects of chloroquine on blood glutathione S-transferases M1 and A
001824 (1996) Maxwell Sehested [Danemark] ; Peter Buhl Jensen [Danemark]Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle
001829 (1996) B. Holm [Danemark] ; Peter Buhl Jensen [Danemark] ; Maxwell Sehested [Danemark]ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors
001941 (1995) James F. Eliason [Japon] ; Henri Ramuz [Suisse] ; Takashi Yoshikubo [Japon] ; Tohru Ishikawa [Japon] ; Taeko Yamamoto [Japon] ; Takashi Tsuruo [Japon]Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro
001982 (1995) Charles B. Pratt [États-Unis] ; Laura C. Bowman [États-Unis] ; Neyssa Marina [États-Unis] ; Alberto Pappo [États-Unis] ; Loraine Avery [États-Unis] ; Xiaolong Luo [États-Unis] ; William H. Meyer [États-Unis]A phase I study of sulofenur in refractory pediatric malignant solid tumors
001A54 (1994) Patricia J. Evans [Royaume-Uni] ; Dola Akanmu [Royaume-Uni] ; Barry Halliwell [Royaume-Uni]Promotion of oxidative damage to arachidonic acid and α 1-antiproteinase by anti-inflammatory drugs in the presence of the haem proteins myoglobin and cytochrome C
001B64 (1993) Melvin S. Center [États-Unis]Non-P-glycoprotein multidrug resistance in cell lines which are defective in the cellular accumulation of drug
001B87 (1993) Ulrich E. Honegger [Suisse] ; Roger D. Zuehlke [Suisse] ; Isabel Scuntaro [Suisse] ; Markus H. A. Schaefer [Suisse] ; Hermann Toplak [Suisse] ; Ulrich N. Wiesmann [Suisse]Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Biochem pharmacol" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Biochem pharmacol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Biochem pharmacol
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021